No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MLTX241220P25000
- 0.45
- 0.000.00%
15min DelayClose Dec 20 16:00 ET
0.00High0.00Low
0.45Open0.45Pre Close0 Volume3 Open Interest25.00Strike Price0.00Turnover0.00%IV52.94%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.45Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma115.93Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
MoonLake Immunotherapeutics Announces Board Changes and Incentives
Clear Street Launches Healthcare & Biotechnology Equity Research
Stifel Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Raises Target Price to $77
We Think MoonLake Immunotherapeutics (NASDAQ:MLTX) Can Afford To Drive Business Growth
Jefferies Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Maintains Target Price $65
LifeSci Capital Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Maintains Target Price $75